Cardiometabolic News and Research

RSS

UAB at the forefront of diabetes research and training

The National Institutes of Health (NIH) has designated the University of Alabama at Birmingham (UAB) one of only six Diabetes Research and Training Centers (DRTC) in the country, putting UAB at the forefront in the development of new methods to treat, prevent and, ultimately, cure diabetes and its complications.

4 Apr 2008

With obesity, diabetes and cardiovascular disease on the rise, more comprehensive guidelines needed

According to new survey results, when 2007 Cardiometabolic Health Congress participants were asked what guidelines they follow for treating patients with multiple cardiovascular and metabolic risk factors, the largest group of respondents indicated that they didn't follow any particular set of guidelines and that better guidelines are needed.

12 Dec 2007

Binge drinking by adolescents increases long-term risk for heart disease

New research into lifelong alcohol consumption reveals that heavy binge drinking by adolescents and young adults is associated with increased long-term risk for heart disease, high blood pressure, type 2 diabetes, and other metabolic disorders.

21 Nov 2007

Scale back on weight obsession, urges obesity expert

"We need to change how we look at obesity, stop obsessing on weight and BMI and, above all, redefine the proper clinical use of weight loss drugs," says noted obesity expert Dr. Jean-Pierre Després, delivering the Heart and Stroke Foundation of Canada Lecture at the Canadian Cardiovascular Congress 2007.

22 Oct 2007

Children who are obese or who are at risk for obesity show early signs of heart disease

Childhood obesity in the United States is an epidemic -- nationwide, 19 percent of children ages 6 to 11 and 17 percent of those 12 to 19 are overweight, according to the Centers for Disease Control and Prevention (CDC). Those who are overweight during childhood also have an increased risk of obesity in adulthood and are at greater risk for complications such as diabetes, high blood pressure and heart disease, because obesity increases total blood volume, which leads to extra stress on the heart.

18 Oct 2007

Concerns noted on study of soft drinks and metabolic syndrome

A recent observational study reported in the journal Circulation ("Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome in Middle-Aged Adults") needs to be considered in the proper scientific context, especially in relation to other previously published research that has reached the opposite conclusion.

26 Jul 2007

Twin study on the increased cardiometabolic risk in obesity

A unique monozygotic twin study by researchers from the Finnish Twin Cohort, Helsinki University Central Hospital, and VTT Technical Research Centre of Finland found that obesity, already in its early stages and independent of genetic influences, is associated with deleterious alterations in the lipid metabolism known to facilitate atherogenesis, inflammation and insulin resistance.

15 Feb 2007

Study highlights differences in Anthropometric characteristics between Asian and European population

World Congress of Cardiology Report - Results from a large scale international study assessing prevalence of abdominal obesity in over 170,000 people have previously confirmed that a high waist circumference is associated with cardiovascular disease (CVD) independently of body mass index (BMI) and age.

5 Sep 2006

Endocannabinoid system shows promise in combating obesity

As the obesity epidemic grows in the United States, the medical community is faced with the significant challenge of properly treating patients before complications such as heart disease arise.

3 May 2006

Forget the bathroom scales and get out the tape measure!

A new study has found that waist measurements are a better indicator of cardiovascular disease (CVD) than body mass index (BMI).

16 Mar 2006

Rimonabant produces sustained weight loss long term

Use of the weight-loss medication rimonabant produced modest yet sustained weight loss after 2 years, and improved HDL cholesterol and triglyceride levels, according to a study in the February 15 issue of JAMA: The Journal of the American Medical Association.

17 Feb 2006

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

The reported results of a one-year phase III study in 1045 people with type 2 diabetes treated with rimonabant, the first in a new class of therapeutic agents called selective CB1 Blockers, were that rimonabant 20 mg significantly improved HbA1c (a measure of blood sugar control), dyslipidemia (abnormal levels of fat in the blood), and systolic blood pressure with a concomitant substantial reduction in abdominal obesity in people with type 2 diabetes treated with oral anti-diabetic medications and requiring further control.

12 Jun 2005